Otsuka Pharmaceutical to Acquire Transcend Therapeutics

AI Briefing

• – Otsuka Pharmaceutical to Acquire Transcend Therapeutics
• – Acquisition expands Otsuka's portfolio in psychiatric and neurological fields
• – Aims to accelerate development of Transcend's PTSD treatment, TSND-201